I have consulted on civil and criminal cases involving brain injuries, dementia, substance abuse leading to neuropathological processes, medical errors, birth trauma, perinatal brain damage, as well as complex medical problems that lead to death. Most of my practice has been on the side of the plaintiff/complainant. Last 2 cases (2022): 1) against a plastic surgeon who failed to examine the patient for deep vein thrombosis–patient died from pulmonary emboli shortly after surgery; 2) defense- stillbirth with a complicated medical course exacerbated by congenital brain anomalies. I have testified in court and given depositions.

Dr. Suzanne de la Monte is a physician scientist who directs basic and translational research in the laboratory. She also performs clinical service work in Neuropathology. This activity includes teaching residents and students. Her research efforts are mainly focused on understanding the role of insulin and insulin-like growth factor resistance in relation to neurodegeneration caused by Alzheimer’s disease and chronic alcohol abuse.

I am a Professor in Pathology and Laboratory Medicine, Neurology, & Neurosurgery at the Warren Alpert Medical School of Brown University, Chief of Pathology & Laboratory Medicine at the Providence VA Medical Center, and medical staff member at the Rhode Island Hospital and Women and Infants Hospital of Rhode Island. Between medical school and residency training, I was a research fellow at the National Institutes of Health. I received residency training in Anatomic and Pediatric Pathology at Johns Hopkins and fellowship training in Neuropathology at the Massachusetts General Hospital (MGH). Throughout my education from my freshman year in college, I conducted research. Those early experiences led me to become a researcher. I launched her career as a physician-scientist while on the faculty at MGH and Harvard Medical School. In 2000, I joined the faculty at Rhode Island Hospital and Brown where I continue to lead programs in basic, translational, and clinical research on mechanisms and consequences of brain insulin resistance and metabolic dysfunction, which I have termed, ‘Type 3 Diabetes’. My laboratory also investigates how lifestyle exposures, including nitrosamines, cause neurodegeneration linked to brain insulin resistance (Type 3 diabetes) and evaluates novel approaches for therapeutic targeting of brain metabolic defects. Thus far, I have published over 300 peer-reviewed articles and have delivered many national and international presentations on my research.

Education: 

• A.B., Cornell University
• M.D., Weill-Cornell Medical College
• M.P.H., Johns Hopkins Bloomberg School of Public Health